Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing

John B. Bundrick; David A. Cook; Bobbie S. Gostout

doi:10.4065/80.8.1063

Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing

John B. Bundrick, David A. Cook, Bobbie S. Gostout

Research output: Contribution to journal › Review article › peer-review

10 Scopus citations

Abstract

New techniques for cervical cancer screening and a better understanding of the natural history of human papillomavirus (HPV) and cervical neoplasia have inspired a quest for more rational screening strategies for cervical cancer. Often, screening intervals for women older than 30 years can be expanded safely to every 3 years, and experts now agree that screening may cease after hysterectomy and in elderly women (provided certain criteria have been met). Liquid-based cytology produces more satisfactory specimens than conventional testing and offers the valuable option of treating atypical squamous cells of undetermined significance by "reflex" testing for high-risk types of HPV on the original specimen. Testing for HPV as an adjunct to cervical cytology for primary screening is now considered reasonable for many women older than 30 years.

Original language	English (US)
Pages (from-to)	1063-1068
Number of pages	6
Journal	Mayo Clinic proceedings
Volume	80
Issue number	8
DOIs	https://doi.org/10.4065/80.8.1063
State	Published - Aug 2005

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.4065/80.8.1063

Cite this

@article{2b7cb6fb483c45a4832978009ce98f62,

title = "Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing",

abstract = "New techniques for cervical cancer screening and a better understanding of the natural history of human papillomavirus (HPV) and cervical neoplasia have inspired a quest for more rational screening strategies for cervical cancer. Often, screening intervals for women older than 30 years can be expanded safely to every 3 years, and experts now agree that screening may cease after hysterectomy and in elderly women (provided certain criteria have been met). Liquid-based cytology produces more satisfactory specimens than conventional testing and offers the valuable option of treating atypical squamous cells of undetermined significance by {"}reflex{"} testing for high-risk types of HPV on the original specimen. Testing for HPV as an adjunct to cervical cytology for primary screening is now considered reasonable for many women older than 30 years.",

author = "Bundrick, {John B.} and Cook, {David A.} and Gostout, {Bobbie S.}",

year = "2005",

month = aug,

doi = "10.4065/80.8.1063",

language = "English (US)",

volume = "80",

pages = "1063--1068",

journal = "Mayo Clinic Proceedings",

issn = "0025-6196",

publisher = "Elsevier Science",

number = "8",

}

TY - JOUR

T1 - Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing

AU - Bundrick, John B.

AU - Cook, David A.

AU - Gostout, Bobbie S.

PY - 2005/8

Y1 - 2005/8

N2 - New techniques for cervical cancer screening and a better understanding of the natural history of human papillomavirus (HPV) and cervical neoplasia have inspired a quest for more rational screening strategies for cervical cancer. Often, screening intervals for women older than 30 years can be expanded safely to every 3 years, and experts now agree that screening may cease after hysterectomy and in elderly women (provided certain criteria have been met). Liquid-based cytology produces more satisfactory specimens than conventional testing and offers the valuable option of treating atypical squamous cells of undetermined significance by "reflex" testing for high-risk types of HPV on the original specimen. Testing for HPV as an adjunct to cervical cytology for primary screening is now considered reasonable for many women older than 30 years.

AB - New techniques for cervical cancer screening and a better understanding of the natural history of human papillomavirus (HPV) and cervical neoplasia have inspired a quest for more rational screening strategies for cervical cancer. Often, screening intervals for women older than 30 years can be expanded safely to every 3 years, and experts now agree that screening may cease after hysterectomy and in elderly women (provided certain criteria have been met). Liquid-based cytology produces more satisfactory specimens than conventional testing and offers the valuable option of treating atypical squamous cells of undetermined significance by "reflex" testing for high-risk types of HPV on the original specimen. Testing for HPV as an adjunct to cervical cytology for primary screening is now considered reasonable for many women older than 30 years.

UR - http://www.scopus.com/inward/record.url?scp=23244437744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23244437744&partnerID=8YFLogxK

U2 - 10.4065/80.8.1063

DO - 10.4065/80.8.1063

M3 - Review article

C2 - 16092586

AN - SCOPUS:23244437744

SN - 0025-6196

VL - 80

SP - 1063

EP - 1068

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

IS - 8

ER -

Screening for cervical cancer and initial treatment of patients with abnormal results from papanicolaou testing

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this